Adagene (NasdaqGM:ADAG) FY Conference September 08, 2025 11:00 AM ET Company ParticipantsMickael Chane-Du - Chief Strategy OfficerYu He (Arthur) - VP - Equity ResearchYu He (Arthur)Good morning, everyone. Thanks for joining us today. My name is Arthur, Senior Biotech Analyst at H.C. Wainwright. Thanks for joining us to have a conversation with Mr. Michael Chane-Du, the Chief Strategy Officer of Adagene Inc. Adagene is a clinical-stage biopharmaceutical company focused on developing next-generation antibody ...